Dr Kristi Kuper, Pharm.D., BCPS

Dr Kristi Kuper, Director of Clinical Pharmacy, DoseMe

Dr. Kuper is a Board Certified Pharmacotherapy Specialist who has spent the last 20 years in a variety of clinical pharmacy leadership roles working with more than 500 hospitals. She has contributed to over 40 publications and has experience co-leading national research projects on under-researched areas in antibiotic stewardship.

She is a recognized expert in the use of clinical decision support to improve medication utilization in the acute care setting. She received her Doctor of Pharmacy from the University of Nebraska Medical Center and completed a pharmacy practice residency at the James A Haley Veterans Hospital in Tampa, Florida. She currently resides in Houston, Texas.

American College of Clinical Pharmacy
- ID Practice and Research Network, Secretary-Treasurer 2010-2011
American Society of Health-System Pharmacists
Board of Pharmaceutical Specialties
Houston Infectious Diseases Network
Infectious Disease Society of America
Society of Infectious Diseases Pharmacists
- Internet Committee 2012-2017
  - Vice chairperson 2013-2014, Chairperson 2014-2015
- Antimicrobial Stewardship Committee, 2010-2011
- Interorganizational Relations Committee, 2009-2011, 2017
- Membership Committee, 2010-2011
- Newsletter Committee 2006-2009
  - Chairperson 2008-2009
- Policy and Government Affairs Committee, 2016- current
  - Vice chairperson 2018-2019
  - Chairperson 2019-2020
- SIDPEC Educational Committee – 2016 – 2019
Society of Healthcare Epidemiology of America
- Antimicrobial Stewardship Committee, 2015 – 2018
- Antibiotic Stewardship Track Chair; National Meeting, 2019
- PPGA Committee – 2020 – current

2019 – 2022 Director of Clinical Pharmacy, DoseMeRx/Tabula Rasa HealthCare
2016 – 2019 Sr. Clinical Manager, Infectious Diseases, Vizient Inc.
2013 – 2016 Sr. Clinical Manager, Vizient, Inc.
2005 – 2013 Clinical Director, Infectious Diseases, Cardinal Health Pharmacy Solutions
Houston, TX.
2004 – 2005 Clinical Director, Pharmacy Management, Cardinal Health Pharmacy Solutions
Houston, TX.
2002 – 2004 Project Manager (Clinical), Cardinal Health Clinical Services and Consulting
Houston, TX.
2000 – 2002 Pharmacy Clinical Coordinator, Olathe Medical Center, Olathe, KS.
2000 – 2001 PRN Staff Pharmacist, Miami County Medical Center, Paola, KS.
1999 – 2000 Pharmacy Practice Residency, JA Haley Veterans’ Hospital, Tampa, FL.

2020 Certified MedWise Advisor
2005 Graduate of Pharmacy Leadership Institute, Boston University, Boston, MA.
2002 Board Certified Pharmacotherapy Specialist (recertified 2009 and 2016)

2018 – current Graduate Certificate in Biomedical Informatics, University of Texas Health Sciences Center, Houston, TX (currently enrolled)
1999 – 2000 ASHP Accredited Pharmacy Practice Residency, James A. Haley Veterans’ Hospital, Tampa, FL
1995 – 1999 Doctor of Pharmacy, University of Nebraska Medical Center, Omaha, NE
1992 – 1995 Pre-Pharmacy, University of Nebraska at Omaha, Omaha, NE
1991 – 1992 Business major, Bellevue University, Bellevue, NE

2019 SHEA National Meeting Planning Committee
2018 Joint Commission Expert Advisory Group on Antimicrobial Stewardship
2017 CDC/Pew Trust/ AHA Advisory Group on Small and Critical Access Hospitals
2017 Technical Advisor AHRQ Safety Program for Improving Antibiotic Use
2016 City of Houston Antimicrobial Stewardship Taskforce Planning Committee
2016 City of Houston Antimicrobial Stewardship Antibiotic Stewardship Taskforce
2015 Invited Participant at the White House Forum on Antimicrobial Stewardship
2015 National Quality Forum Advisory Group on Antimicrobial Stewardship
2015 CDC /Pew Trust Advisory Group. Inpatient Antibiotic Prescribing: Setting a National Goal for Reducing Inappropriate Use (2015-2016)
2015 Society for Healthcare Epidemiology of America Antimicrobial Stewardship Task Force
2012 Society for Healthcare Epidemiology of America Workgroup on Antibiotic Stewardship
2010 Adjunct Professor of Pharmacy Practice, University of Houston College of Pharmacy
2010 Institute for Healthcare Improvement (IHI) Antibiotic Stewardship Driver Diagram Committee
2009 CDC/RFF Workgroup on Inpatient Antibiotic Use
2009 Adjunct Professor of Pharmacy Practice, Texas Southern University

Blumenthal KG, Kuper K, Schulz LT, et al. Association Between Penicillin Allergy Documentation and Antibiotic Use [published online ahead of print, 2020 Jun 29]. JAMA Intern Med. 2020;e202227. doi:10.1001/jamainternmed.2020.2227
Mancini CM, Kuper K, Schulz LT, Bhowmick T, Postelnick M, Lee F, Blumenthal KG. R Reply to Bland and Jones. Clin Infect Dis. 2020 Jul 14:ciaa980. doi: 10.1093/cid/ciaa980. Online ahead of print.
Mancini CM, Fu X, Zhang Y, Kuper K, Schulz LT, Bhowmick T, Postelnick M, Lee F, Walensky RP, Blumenthal KG. Penicillin allergy evaluation access: A national study. Clin Infect Dis 2020; ciaa567. doi: 10.1093/cid/ciaa567. Online ahead of print.
Kuper KM, Hamilton K. Collaborative Antimicrobial Stewardship: Working with Information Technology. Infect Dis Clin North Amer 2020 Mar;34(1):31-49. doi: 10.1016/j.idc.2019.10.005. Epub 2019 Dec 10.
Newton J, Robinson S, Li Ling CL, Zimmer, L,Kuper K, Trivedi K. Impact of procalcitonin levels combined with active intervention on antimicrobial stewardship in a community hospital. Open Forum Infect Dis 2019;11(6):ofz355.
Kuper K, Nagel J, Kile J, May L, Lee F. SHEA White Paper: The role of electronic health record and “Add on” clinical decision support systems to enhance antimicrobial stewardship programs. Infection Control and Healthcare Epidemiology2019;40(5):501-511.
Endres T, Begum K, Sun H, Walk ST, Memariani A, Lancaster C, Gonzales-Luna AJ, Dotson KM, Bassères E, Offiong C, Tupy S, Kuper K, Septimus E, Arafat R, Alam R, Zhao, JG Hurdle, Savidge TC, Garey KW. Epidemic Clostridiodes difficileribotype 027 lineages: Comparison of Texas Versus Worldwide Strains. Open Forum Infect Dis. 2019 Feb 9;6(2):ofz013.
Kuper K, Lee F. Informatics and Stewardship. In: Antibiotic Stewardship, Society of Healthcare Epidemiology of America, First edition. Cambridge University Press, New York, NY; 2018: 206-219.
Williams M,Kuper K. Overview of Regulatory Issues in Antimicrobial Stewardship. In: Updates in Therapeutics 2018: Ambulatory Care Pharmacy Preparatory Review and Recertification Course. Infectious Diseases I. American College of Clinical Pharmacy, Lenexa, KS; 2018: 135-140.
Foster RA, Kuper K, Lu ZK, Bookstaver PB, Bland CM, Mahoney MV. Pharmacists’ familiarity with and institutional utilization of rapid diagnostic technologies for antimicrobial stewardship. Infect Control Hosp Epidemiol2017;1-4.
Kuper K, Schilling A. Antimicrobial Resistance. In: Pharmacotherapy Self-Assessment Program, 2015 Book I. Infectious Diseases: American College of Clinical Pharmacy, Lenexa, KS; 2015:61-83.
Garey KG, Aitkin SL, Dima-Ala A, Beyda ND, Kuper K, Xie Y, Koo HL. Echinocandin use in hospitalized patients: A multi-institutional study. Am J Medical Sciences2015;349:316-320.
Trivedi KK, Kuper KM. Hospital antimicrobial stewardship in the non-academic setting. Infectious Diseases Clinics North America2014; 28: 281-289.
Quidley A, Bland CM, Bookstave BB, Kuper K. Perioperative management of bariatric surgery patients. Am Journal of Health Systems Pharmacists2014;71: 1253- 64.
Jacobs D, Kuper K, Septimus E, Arafat R, Garey K. Assessment of antimicrobial stewardship practices in a large, metropolitan area. Journal of Pharmacy Practice2014.
Bowers DR, Hunter AS, Jacobs DM, Kuper KM, Musick WL, Perez KK, Shah DH, Schilling AN. Significant publications on infectious diseases pharmacotherapy in 2012. American Journal of Health Systems Pharmacists 2013; 70 (21): 1930-40.
Kuper KM, Coyle E, Wanger A. Antifungal susceptibility testing: A primer for clinicians. Pharmacotherapy2012; 32(12):1112-1122.
Michaels K, Mahdavi M, Krug A,Kuper K. Implementation of an Antimicrobial Stewardship Program in a Community Hospital: Results of a Three-Year Analysis. Hospital Pharmacy 2012;47(8):608–616.
Kuper KM, Boles DM, Mohr JF, Wanger A. Antibiotic susceptibility testing: A primer for clinicians. Pharmacotherapy2009;29(11):1326-1343.
Kuper KM, Hirsch EB, Tam VH on behalf of the Houston Infectious Disease Network. Significant publications on infectious diseases pharmacotherapy in 2008.American Journal of Health Systems Pharmacists 2009; 66:1726-34.
Septimus EJ and Kuper KM. Clinical challenges in addressing resistance to antimicrobial drugs in the twenty-first century. Clin Pharmacology and Therapeutics.2009;86(3):336-39.
Kuper KM and Septimus EJ. Healthcare associated infections: The legislative landscape and the pharmacists’ role. American Journal of Health Systems Pharmacists2009;66(5):488-94.
Yeh RF, Kuper KM, Coyle EA, et al. Significant papers in infectious diseases pharmacotherapy in 2007. American Journal of Health Systems Pharmacists. 2008;65(22):e72-9.
Kuper K.Antibiotic Streamlining. In: Murdaugh LB, editor. Competence Assessment for Hospital & Health-System Pharmacies, 4th Edition. ASHP, Bethesda, Maryland; 2007.
Kuper K.Intravenous to Oral Therapy Conversion. In: Murdaugh LB, editor. Competence Assessment for Hospital & Health-System Pharmacies, 4th Edition. ASHP. Bethesda, Maryland; 2007.
You can see a list of Kristi Kuper’s Academic Publications here and here.

Dr Kristi Kuper, Pharm.D., BCPS

Societies/Organizations

Professional Positions

Certificates/Awards

Academic Experience

Appointments

Publications